Expert consensus on long-term medication for breast cancer integrating Chinese and Western medicine
With the prolongation of the survival period of breast cancer patients,the issue of long-term medication for breast cancer has attracted widespread attention.However,there are currently no relevant guidelines or consensus provi-ding comprehensive guidance and standards for the integration of Chinese and Western medicine in the long-term medica-tion of breast cancer patients.The Professional Committee for Holistic Integrative Chinese and Western Medicine in Breast Cancer Treatment of the China Anti-Cancer Association held three symposiums specifically addressing the issue of long-term concurrent use of Chinese and Western medicines in breast cancer patients,ultimately formulating this consen-sus.This consensus aims to further improve the long-term medication compliance of breast cancer patients,enabling pa-tients to achieve effective duration of drug use,and improve their quality of life and prolong survival.
breast cancerlong-term medicationholistic integrative medicinethe integration of Chinese and Western med-icineexpert consensus
NETL
NSTL
万方数据
